Project Number 1R61AG074859-01 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for GM-CSF/sargramostim treatment to improve cognition in Down syndrome Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator POTTER, HUNTINGTON Principal Investigator First Name HUNTINGTON Principal Investigator Last Name POTTER Awardee Organization UNIVERSITY OF COLORADO DENVER Awardee State Colorado Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-OD-20-003: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) FY Overall Cost $345,544 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
